April 9, 2026
Faster ROI
The 2026 ROI reset: the playbook for Benefit Leaders
In 2026, benefits strategies are judged on hard-dollar ROI, measurable claims impact, and defensible financial outcomes. Engagement alone no longer defines success and CFOs are compressing ROI timelines from years to months.
This guide shows you how to adapt fast. Learn how leading organizations are building measurement frameworks that stand up to financial scrutiny, and executing benefits strategies that deliver returns within 6–12 months.
We also share the proven savings that implementing Sword can generate within plan year by reducing avoidable surgeries and slashing MSK costs.
84%
Reduction in low-value MSK surgeries, demonstrated in peer-reviewed research
$2,370
Potential per-member per-year savings from reduced low-value MSK care
What the guide helps you analyze
This playbook shows how leading benefits teams evaluate ROI using claims impact, utilization changes, and defensible measurement frameworks. Get specific advice on how to assess vendor claims, interpret validated ROI evidence, and identify the highest-cost categories where conservative and preventative care can shift cost trajectories fast.
Whether you're preparing for renewal season or building the next generation of your benefits strategy, this guide provides the frameworks benefits leaders need to measure, execute, and defend ROI in today’s healthcare environment.
Key learnings inside the guide
- How to reshape your benefits strategy to deliver ROI in 6-12 months
- Renewal-ready measurement frameworks that stand up to finance scrutiny
- The most common ROI calculation mistakes that undermine vendor claims and how to avoid them
- Practical advice to help you assess vendor claims and spot empty promises before you commit to a contract
Insights sourced from benefits strategy experts
This playbook was developed by Sword's internal healthcare benefits experts including Candace Jodice (Head of Benefits Strategy), Jeannette Abbot (Head of Ecosystem Relationships), Akshat Pradhan (Director of Actuarial Services, Health Economics), Fabiola Costa (Sr. Director of Clinical Research), and Carolina Marramaque (Chief of Staff, Clinical R&D), along with input from Sword's Client Advisory Board of more than 50 benefits leaders from Fortune 500 companies.
Contributors to White Paper

Exploring the breakthroughs behind AI Care